DBCO-β-Glu-PEG12-Exatecan
DBCO-β-Glu-PEG12-Exatecan (Compound 107) is an inhibitor for topoisomerase I. DBCO-β-Glu-PEG12-Exatecan can be used as a Drug-Linker Conjugate for ADC molecule[1].
Product Specifications
CAS Number
3025107-83-6
UNSPSC
12352005
Target
Drug-Linker Conjugates for ADC; Topoisomerase
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dbco-β-glu-peg12-exatecan.html
Purity
98.63
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
Molecular Formula
C92H117FN8O30
Molecular Weight
1833.95
References & Citations
[1]BAJJURI K, et al., β-GLUCURONIDE LINKER-PAYLOADS, PROTEIN CONJUGATES THEREOF, AND METHODS THEREOF. WO2024006272.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Camptothecins
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Guanine nucleotide-binding protein alpha-q / GNAQ / G-ALPHA-q (GNAQ/2434), CF405S conjugate, 0.1mg/mL
![PDSS2 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1D12]](https://cdn.genprice.uk/products/937/68dd1b6d061270361ea16d33/imageurl/ta503951bm.webp)